Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
9.49
+0.66 (7.47%)
Jul 21, 2026, 3:09 PM EDT - Market open
Niki BioSolutions Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.45 | 0.87 | 2.01 | 1.88 | 8.13 |
Short-Term Investments | - | - | - | 0.1 | 0.24 |
Cash & Short-Term Investments | 3.45 | 0.87 | 2.01 | 1.99 | 8.37 |
Cash Growth | 294.96% | -56.41% | 1.02% | -76.28% | -73.75% |
Accounts Receivable | - | - | 0.05 | 0.17 | 0.08 |
Other Receivables | - | 0 | 0.02 | 0.34 | 0.17 |
Receivables | - | 0 | 0.07 | 1.39 | 3.61 |
Inventory | - | - | - | 0.03 | 0.04 |
Prepaid Expenses | 0.06 | 0.07 | 0.1 | 0.22 | 0.22 |
Restricted Cash | - | - | - | 3.13 | 0.13 |
Other Current Assets | 0.08 | 0.01 | 0.3 | 0.32 | 0.33 |
Total Current Assets | 3.59 | 0.96 | 2.48 | 7.07 | 12.69 |
Property, Plant & Equipment | - | - | 1.85 | 3.17 | 3.89 |
Long-Term Investments | 15.1 | 15.1 | 16.1 | 9.74 | 4.16 |
Other Intangible Assets | - | - | 0.15 | 0.19 | 0 |
Other Long-Term Assets | - | 0.07 | 0.07 | 0.69 | 1.17 |
Total Assets | 18.69 | 16.13 | 20.64 | 20.87 | 21.91 |
Accounts Payable | 0.06 | 0.01 | 0.02 | 0.12 | 0.14 |
Accrued Expenses | 1.09 | 0.98 | 1.96 | 6.06 | 4.04 |
Short-Term Debt | 3.42 | 3.24 | - | 6.01 | - |
Current Portion of Leases | 0.02 | 0.1 | 0.13 | 0.31 | 0.19 |
Other Current Liabilities | - | 0 | - | 0 | 0.01 |
Total Current Liabilities | 4.59 | 4.34 | 2.1 | 12.5 | 4.38 |
Long-Term Debt | - | - | 3.06 | 0.5 | - |
Long-Term Leases | - | 0.01 | 0.1 | 0.03 | 0.02 |
Other Long-Term Liabilities | 0.35 | - | - | - | - |
Total Liabilities | 4.95 | 4.35 | 5.26 | 13.03 | 4.4 |
Common Stock | 0 | 0 | 0 | 35.71 | 35.64 |
Additional Paid-In Capital | 97 | 93.47 | 93.02 | 45.31 | 43.51 |
Retained Earnings | -73.79 | -72.43 | -68.16 | -65.34 | -55.54 |
Comprehensive Income & Other | -0.09 | 0.09 | -0.01 | 0.03 | -0 |
Total Common Equity | 23.12 | 21.13 | 24.85 | 15.71 | 23.61 |
Minority Interest | -9.37 | -9.36 | -9.46 | -7.88 | -6.1 |
Shareholders' Equity | 13.74 | 11.78 | 15.38 | 7.83 | 17.51 |
Total Liabilities & Equity | 18.69 | 16.13 | 20.64 | 20.87 | 21.91 |
Total Debt | 3.44 | 3.35 | 3.28 | 6.85 | 0.22 |
Net Cash (Debt) | 0.01 | -2.48 | -1.28 | -4.87 | 8.15 |
Net Cash Growth | - | - | - | - | -72.08% |
Net Cash Per Share | 0.01 | -4.55 | -2.83 | -13.64 | 23.27 |
Filing Date Shares Outstanding | 0.81 | 0.71 | 0.55 | 0.36 | 0.36 |
Total Common Shares Outstanding | 0.81 | 0.56 | 0.52 | 0.36 | 0.36 |
Working Capital | -1 | -3.38 | 0.38 | -5.44 | 8.31 |
Book Value Per Share | 28.38 | 37.68 | 47.95 | 44.00 | 66.24 |
Tangible Book Value | 23.12 | 21.13 | 24.7 | 15.52 | 23.6 |
Tangible Book Value Per Share | 28.38 | 37.68 | 47.67 | 43.47 | 66.22 |
Machinery | - | - | 4.81 | 6.85 | 4.77 |
Construction In Progress | - | - | - | - | 1.9 |
Leasehold Improvements | - | - | 0.54 | 0.54 | 0.54 |